Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is aggressive or moderate lipid lowering more effective in slowing vascular calcification in postmenopausal women?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 20–21 (2006)Cite this article

boxed-textRaggi P et al. (2005) Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES). Circulation 112: 563–571

Despite a lack of effect on progression of coronary calcification, statin therapy remains invaluable

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Greenland P et al. (2004) Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291: 210–215

    Article  CAS  Google Scholar 

  2. Parhami F et al. (1997) Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17: 680–687

    Article  CAS  Google Scholar 

  3. Callister TQ et al. (1998) Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339: 1972–1978

    Article  CAS  Google Scholar 

  4. Arad Y et al. (2005) Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin E, and vitamin C. J Am Coll Cardiol 46: 166–172

    Article  CAS  Google Scholar 

  5. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7–22

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Cholesterol and Lipid Management Center and Cholesterol, Hypertension, and Atherosclerosis Management Program,

    Karol E Watson, Benjamin Ansell & Gregg C Fonarow

  2. Comprehensive Health Program,

    Karol E Watson, Benjamin Ansell & Gregg C Fonarow

  3. Ahmanson UCLA Cardiomyopathy Center,

    Karol E Watson, Benjamin Ansell & Gregg C Fonarow

  4. UCLA Medical Center, CA, USA

    Karol E Watson, Benjamin Ansell & Gregg C Fonarow

Authors
  1. Karol E Watson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin Ansell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gregg C Fonarow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karol E Watson.

Ethics declarations

Competing interests

B Ansell has received speaking honoraria from AstraZeneca, Pfizer and Kos and consultancy honoraria from AstraZeneca and Pfizer. He has received research grants from Merck and Pfizer, and has stock ownership in Pfizer and Bruin Pharma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watson, K., Ansell, B. & Fonarow, G. Is aggressive or moderate lipid lowering more effective in slowing vascular calcification in postmenopausal women?. Nat Rev Cardiol 3, 20–21 (2006). https://doi.org/10.1038/ncpcardio0421

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0421

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing